주요 콘텐츠로 건너뛰기
HeritableHealthHeritable Health
Choose language
가입하기
Telegenomics for the Modern Patient

Health genomics, explained with evidence.

Explore health-genomics markers through a tier-graded evidence library that separates established findings from emerging research. New personalized-report and consultation intake is paused; join the waitlist for availability updates.

A clinician and patient reviewing a DNA sequence together on a tablet
  • HIPAA-covered entity
  • Health-genomics education
  • 5-tier evidence grading
  • Encrypted, isolated data
What we do
i.

Tier-graded evidence

Every marker we surface carries an evidence tier: STRONG, VALIDATED, MODERATE, EMERGING, or EXPLORATORY. You see what’s clinically actionable today, what’s still under investigation, and where the boundary sits. No false certainty.

ii.

Clinician interpretation

Our evidence library explains how published genomic findings are graded and why personal and family history matter when a qualified clinician interprets genetic data.

iii.

Care coordination

We connect marker context to questions people can bring to their existing healthcare providers, including when confirmatory testing may be worth discussing.

How we grade evidence

Every finding carries an evidence tier.

You see what is clinically actionable today, what is still under investigation, and where the boundary sits. No false certainty.

  1. 01
    강한
    Clinical consensus
  2. 02
    Validated
    Guideline and FDA backed
  3. 03
    보통
    Replicated findings
  4. 04
    Emerging
    Active research
  5. 05
    Exploratory
    Early signal

Common concerns with direct-to-consumer DNA testing.

The clinical necessity of oversight

Direct-to-consumer (DTC) genetic testing provides a broad overview of your genomic profile, yet the clinical interpretation of these findings requires professional oversight. A genetic clinician contextualizes raw data within your personal and family medical history, distinguishing between benign variations and findings that necessitate clinical action.

Professional consultation can place results in context and reduce the risk of unnecessary anxiety or false reassurance from automated reports.

Clinical follow-up and management

If a report identifies markers associated with hereditary conditions, such as predispositions for cardiovascular disease or oncological risks, clinical follow-up is essential. A qualified professional can determine if additional diagnostic-grade testing is required and assist in developing a proactive surveillance or management strategy tailored to your risk profile.

Heritable Health's evidence library connects marker context with questions worth discussing with a qualified clinician, drawing on current clinical standards and peer-reviewed genomic research.

If you have identified a marker of concern, discuss it with a qualified clinician who can review it alongside your personal and family history.

Important DNA markers to discuss with your doctor or genetic counselor.

  • BRCA1 and BRCA2: 유방암과 난소암의 위험을 증가시키는 유전자, 특히 SNPs rs80357906 (BRCA1)과 rs1799950 (BRCA2).
  • MCM6: 이 마커는 락타아제 지속성 또는 유당 불내증과 관련이 있으며, 특히 SNP rs4988235와 관련이 있습니다.
  • FTO: 비만 및 제2형 당뇨병과 관련이 있으며, 특히 SNP rs9939609와 관련이 있습니다.
  • APOE: 알츠하이머병과 관련된 SNPs rs429358 및 rs7412.
  • TCF7L2: 이 마커는 제2형 당뇨병과 관련이 있으며, 특히 SNP rs7903146과 관련이 있습니다.
  • OPRM1: 오피오이드 및 알코올 의존성과 관련된 SNP rs1799971.
  • CDKN2A/B: 관상동맥심장병과 관련이 있으며, 특히 SNP rs1333049와 관련이 있습니다.
  • CHRNA3: 니코틴 의존성과 관련된 SNPs rs1051730 및 rs3750344.
  • CFTR: 낭포성 섬유증과 관련이 있으며, 특히 ΔF508 (rs113993960) 및 G551D (rs113993959) 변이가 있습니다.
  • MTHFR: 메틸렌테트라하이드로폴레이트 환원효소 결핍과 관련이 있으며, 특히 SNPs rs1801133 (C677T) 및 rs1801131 (A1298C)와 관련이 있습니다.
  • KCNJ11: 제2형 당뇨병과 관련이 있으며, 특히 SNP rs5219 (E23K)와 관련이 있습니다.

Some markers worth discussing.

A curated selection from the marker library, with evidence tiers and linked references to help you prepare questions for a qualified clinician.

BRCA1 breast cancer 1 gene (rs55770810)

Interested in personalized guidance?

Join the waitlist for updates when personalized reports and video consultations accept new intake. The evidence library remains open while you wait.

대기자 명단에 가입하기
Steps to get started

What you can do today.

  1. Step 1

    Explore the evidence library and note the markers you want to understand.

  2. Step 2

    Join the waitlist for personalized-report and consultation availability updates.

  3. Step 3

    If intake opens in your region, we will share the next steps before you provide DNA data.

Frequently asked questions.

텔레제노믹스란 무엇인가요?
지금 상담이 가능한가요?
지금 DNA 데이터를 업로드할 수 있나요?
내 DNA 데이터는 안전한가요?
What if a marker needs follow-up?
상담은 어떻게 진행되나요?

Understanding SNPs and the human genome.

Genomic complexity and variation

The human genome is comprised of approximately 3.2 billion base pairs, and because you inherit one copy from each parent, each of your cells carries about 6.4 billion in total. While the vast majority of our genetic sequence is identical across the species, roughly 10 million positions exhibit variation between individuals. These points of difference represent the biological diversity that influences everything from physical traits to disease susceptibility.

The role of Single Nucleotide Polymorphisms

A single nucleotide polymorphism (SNP) is a variation at a specific position in the DNA sequence. As the most prevalent form of genetic variation, SNPs serve as critical biological markers. By identifying patterns in these variations, clinicians can map genetic predispositions and better understand the underlying mechanisms of various health conditions.

SNP 설명